Jaguar Health Inc (JAGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 3,108 | 2,721 | 2,351 | 2,300 | 2,813 |
| Cost of Goods | 541 | 427 | 430 | 687 | 514 |
| Gross Profit | 2,567 | 2,294 | 1,921 | 1,613 | 2,299 |
| Operating Expenses | 10,370 | 9,918 | 10,566 | 9,857 | 11,600 |
| Operating Income | -7,262 | -7,197 | -8,215 | -7,557 | -8,787 |
| Interest Expense | -162 | -108 | 611 | 248 | 500 |
| Other Income | -2,921 | -2,539 | -542 | -1,504 | 1,383 |
| Pre-tax Income | -10,021 | -9,628 | -9,368 | -9,309 | -7,904 |
| Net Income Continuous | -10,021 | -9,628 | -9,368 | -9,309 | -7,904 |
| Minority Interests | -167 | -136 | -142 | -139 | -126 |
| Net Income | $-9,854 | $-9,492 | $-9,226 | $-9,170 | $-7,778 |
| EPS Basic Total Ops | -26.29 | -2.66 | -87.12 | 2,517.48 | -562.50 |
| EPS Basic Continuous Ops | -26.74 | -2.69 | -88.47 | 2,553.34 | -571.67 |
| EPS Diluted Total Ops | -26.29 | -2.66 | -87.12 | 2,517.48 | -562.50 |
| EPS Diluted Continuous Ops | -26.74 | -2.69 | -88.47 | 2,553.34 | -571.67 |
| EPS Diluted Before Non-Recurring Items | -26.25 | -101.00 | -90.36 | N/A | N/A |
| EBITDA(a) | $-6,666 | $-6,638 | $-7,331 | $-5,256 | $-1,075 |